MedTrace Logo

Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis

NCT01293955 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2015-04-24

No results posted yet for this study

Summary

* A Pilot study
* Randomized and Double-blinded
* Placebo controlled
* In 2 parallel group (JOINS 200mg:Placebo = 1:1)
* Overall 24 months treatment (JOINS:Placebo comparison up to 12 months, Additional follow-up assessment up to 24 months)
* Provide rescue medicine throughout whole clinical trial period.

Conditions

Interventions

DRUG

JOINS 200mg

1 tablet at each time, 3 times a day

DRUG

Placebo

placebo of Joins 200mg

Sponsors & Collaborators

  • SK Chemicals Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Myoungchul Lee, PH.D.. · Orthopedics, Seoul National University hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293955 on ClinicalTrials.gov